Dr Thomas Högberg to head up Mind the Byte office in Scandinavia

10th March 2017

Mind the Byte continues to reinforce its international presence. To this end, Thomas Högberg is joining the company as Business Development Director Scandinavia and Senior Advisor in order to consolidate computational design services in one of the most important pharmaceutical and biotechnology markets in Europe. He will carry out these responsibilities from the company's offices in the Copenhagen Bio Science Park (COBIS). 

Dr Högberg has spent over 45 years in the pharmaceutical industry with experience from big pharma (Astra, AstraZeneca), mid pharma (ALK-Abello, LEO Pharma) and biotech (7TM Pharma) where he headed various departments (medicinal chemistry, chemical research, DMPK, Patent, Project and Portfolio Management). He has had leading roles from early drug discovery to marketed products and worked in several therapeutic areas including dermatology, metabolic diseases, inflammatory diseases, respiratory diseases, CNS diseases, and infection.  He has also been engaged in business development and due diligence in in-and outlicensing in several companies. 

Dr Högberg earned a PhD in Organic Chemistry from Uppsala University (Sweden) and is Assoc Prof at the KTH Royal Institute of Technology in Stockholm and Fellow of the Royal Society of Chemistry (CChem, FRSC). In the scientific arena, he has published over 100 papers and book chapters and is the co-inventor on over 50 patent applications. 

In addition to his experience in the market, Mind the Byte founder and CEO Dr Alfons Nonell-Canals highlights that, "His experience in chairing management evaluation and prioritisation teams will surely help us build a strong new team in Scandinavia." 

Mind the Byte is one of the 245 members of Medicon Valley, one of the most active life sciences clusters and home to more than 140,000 employees. 

Recently, Mind the Byte also appointed Prof Peter Edman and Dr José Luis Cabero to its Advisory Board.